Venous thromboembolism (VTE) is a vascular injury that may manifest as deep vein thrombosis (DVT) or pulmonary embolism (PE) and is reported to occur in 1 in 1,000 people per year in the United States.
1 The prognosis for PE is worse than that of DVT. 2, 3 Approximately 25% of all PE cases present as sudden death, and 15% of patients with PE die within 3 months of diagnosis. 2, 4 However, in patients with firstepisode symptomatic PE, the risk of recurrent, fatal PE after discontinuation of anticoagulants is 4-9%.
3 VTE is significantly more common in those over 65 years of age, but does occur in adolescents and young adults at a rate of .01-.03%.
5
Athletes may be presumed to have a lower risk of VTE; moderate exercise increases blood fibrinolysis while vigorous exercise appears to increase blood coagulation and fibrinolysis concurrently. 6 The incidence of VTE in athletes is not known at this time and reports of this injury are currently limited to case reports and case series reports.
It appears that VTE may be underrecognized and underreported in the athletic population.
7-10 This may be due, in part, to the overlap of symptoms of VTE and more common injuries and conditions, such as gastrocnemius strains, thoracic outlet syndrome, exercise-induced bronchoconstriction. However, the potential catastrophic sequela of VTE requires that members of the athletic health care team be familiar with risk, and factors that increase the risk, of VTE in athletes (Table 1) . PE is recognized as a source of mortality among athletes and has been implicated in 2% of cardiac related deaths among Italian soccer players.
11 Other athletes have survived episodes of PE, increasing our understanding of contributing factors and informing return to activity protocols. 7, 12 The purpose of this paper is to present a case of acute PE in an intercollegiate softball athlete with attention to modifiable risk factors and return to play considerations.
Case Review
A 20-year-old white, female softball player reported to the emergency department (ED) after experiencing acute shortness of breath and severe chest pain while resting at home. She reported increasing left chest discomfort for the preceding 3 days that she had initially attributed to a cold. The athlete had recently resumed physical conditioning after a winter break; she denied any trauma associated with this training.
Venous thromboembolism (VTE) is relatively rare among young, healthy individuals; however, the potential for a catastrophic outcome demands attention to recognition and management.
Risk factors for VTE include surgery, endothelial injury, immobilization, oral contraceptives and obesity; with some risk factors demonstrating a synergistic effect when presented in combination.
Successful return as soon as three months after treatment for pulmonary embolism has been documented. Return to play decisions must be made on a case-by-case basis with consideration of attenuation of individual risk factors. The ED examination included electrocardiography which demonstrated sinus tachycardia, but was otherwise unremarkable, computerized tomography of the chest which demonstrated bilateral extensive pulmonary emboli (Figures 1 and 2) , and duplex sonography which demonstrated no evidence of DVT.
The patient was admitted to the hospital for 2 days, during which time she was treated with intravenous and subcutaneous thrombolytics. She was released with oral warfarin (Coumadin, 10 mg daily) and subcutaneous enoxaparin sodium (Lovenox, 100 mg b.i.d.)
with serial prothrombin time tests to monitor international normalized ratio (INR). Enoxaparin sodium was to be discontinued when INR became therapeutic (2.0-3.0). The patient was advised to discontinue oral contraceptive pills and to avoid exercise while taking anticoagulant medications.
The patient had no known genetic risk factors or disease risk factors. In regard to environmental risk factors, the patient reported using oral contraceptive pills (Yaz; Bayer HealthCare Pharmaceuticals, Wayne, NJ, USA) for two years before the onset of symptoms. Other medications included spironolactone (100 mg, b.i.d.), albuterol (PRN), and sulfamethoxazoletrimethoprim (Bactrim). The patient was overweight with a BMI of 38.4 (5′4″; 224 lbs). Her medical history was positive for seasonal allergies and exercise-induced bronchoconstriction, and she denied a history of smoking, alcohol use, acute trauma, extended travel, and/or immobilization. Her surgical history included 3 orthopedic procedures including arthroscopic labral repair to her left shoulder 9 months prior without any apparent complications.
Two weeks after her hospitalization for PE, the patient discussed the prognosis for returning to intercollegiate softball with her family physician. Both the family physician and team physician advised against a return to play while on anticoagulants; however the patient and her parents aggressively pursued the 
